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eAppendix. Supplementary Materials 
 
EXPANDED METHODS 
Study Participants and Timing of echocardiograms 
The preterm-born and term-born cohorts were both prospectively recruited at birth and followed to 1 
year of age. The preterm infants had echocardiograms performed at 32 weeks postmenstrual age (PMA), 
36 weeks PMA and 1 year corrected age (CA). Term infants were assessed at 1 month and 1 year of age. 
The timings of the echocardiographic studies at 32 and 36 weeks PMA in the preterm infants were pre-
selected to avoid the transitional period of cardiopulmonary and clinic uncertainty and early morbidity 
and associated mortality with extreme preterm birth.1,2 Since the preterm cohort included infants born 
between 23 and 0/7 weeks and 28 and 6/7 weeks gestation at birth, we choose to study all infants at a 
common PMA and a common CA to optimize the determination of the impact of gestational and 
chronological age on cardiac performance at a specific developmental stage and allow for comparison of 
measures between term and preterm infants by post-gestational days from birth.1,2 As previously 
described,3 preterm infants received their first echocardiogram at a median of 38 days (interquartile 
range of 33 to 45 days). Term infants had the initial echocardiogram at a median of 32 days 
(interquartile range of 31 to 35 days). While, the PMA is different between the preterm-born infants (32 
weeks PMA) and term-born infants (range between 41 and 44 weeks PMA) at the 1 month 
echocardiogram, comparing these time points by median days of age allowed for maturational 
comparisons over the first year of age.4 Preterm infants had the second echocardiogram at 36 weeks 
PMA with a median of 67 days (interquartile range of 60 to 76 days). Preterm infants had the third 
echocardiogram (~ 1 year CA) at a median of 494 days (interquartile range of 452 to 521 days). The CA 
in days for all preterm infants was 381 days (355 to 424 days). The term infants received the 1-year of 
age echocardiogram at a median of 378 days (interquartile range of 365 to 399 days).  
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Exclusion criteria for the preterm-born and term-born populations have been previously described.3,5,6 In 
brief, preterm infants were excluded if they had any suspected congenital anomalies of the airways, 
congenital heart disease, fetal growth restriction (FGR)7 or small for gestational age (birth weight < 10th 
centile for gestation). The exclusion criteria for the control cohort were multiple gestation pregnancy, 
maternal smoking, maternal diabetes, antepartum hemorrhage, pre-eclampsia, or proven 
chorioamnionitis. Infants with FGR, perinatal acidosis (umbilical cord pH < 7.10), suspected congenital 
or chromosomal anomalies, neuromuscular disorders, abnormal cardiac rhythms, heart failure, and 
infants readmitted to the hospital within the first year of age were also excluded.  
 
Defining High vs. Low Mothers Own Milk Exposure Groups 
The PROP study design defined high breast milk exposure as greater than 28 days (4 weeks) of 
consumption of mother’s own milk (MoM) feeds before 36 weeks PMA.8 The 28-day cut-off mark was 
chosen to 1) avoid any concerns with missing data and 2) not bias against infants with feeding 
difficulties (eFigure 1). In post-hoc analysis, we determined that to detect right ventricular (RV) 
dysfunction, left ventricular (LV) dysfunction, and elevated RV afterload, cut-off values > 27, 26, and 
30 days of MoM, respectively, resulted in high sensitivity and specificity with large areas under the 
ROC curve (Figure 3 and eFigure 3). As such, in sub-analysis we dichotomized the cohort by high and 
low MoM exposure, defined as greater than 28 days of MoM and compared the values between MoM 
exposure groups and to term born infants at 1 year and 1 month of age (eTable 1 and eTable 2, 
respectively). At the time of the original PROP study design in 2009, most of the data supported the 
effect of three months of breastfeeding in term infants, with little to no data on the threshold on impact 
for preterm infants. As such, preterm-based outcome papers have used breast milk at discharge in their 
analysis (which likely reflects a minimum of three months of the exposure at that point). Since the 
majority of extreme low birth weight preterm infants are discharged after 36 weeks post-menstrual age 
 
© 2021 El-Khuffash A et al. JAMA Network Open. 
(which is >3 months for an extreme preterm infant), we also analyzed the cohort based on their 
discharge nutritional status, MoM vs. bovine formula. To note, as per standard center protocol, infants 
born less than 29 weeks gestation received bovine fortifiers when they reach 100 milliliter per kilogram 
per day of feeds and remained on fortification through discharge. 
 
Echocardiographic Measures 
Echocardiograms were acquired with commercially available ultrasound imaging systems (Vivid 7 and 
E9; General Electric Medical Systems, Milwaukee, Wisconsin). One designated experienced pediatric 
cardiac sonographer obtained all the echocardiographic images using a phased array transducer (5–12 
megahertz).2 Echocardiographic measurements for LV and RV functional, morphometric parameters, 
and estimates of pulmonary hemodynamics were obtained in both term and preterm infants with each 
echocardiographic study. All measures were acquired and analyzed using previously published image 
acquisition and data analysis protocols from our laboratories.2,9 All measures were generated according 
to guidelines of the American Society of Echocardiography10,11 and recent validated protocols in 
neonates.12 Echocardiographic data have previously been published from the preterm cohorts,1,2,4,13,14 
but the measurements had not been previously assessed in relationship to daily milk consumption. We 
have also previously demonstrated excellent reproducibility in term and preterm infants with each of the 
measures described in this section.2,4,13-15  
 
LV Function 
LV function was characterized by the quantification of two dimensional-speckle tracking derived 
deformation imaging. 
A. Deformation: LV free wall longitudinal strain (%) and systolic early, and late diastolic strain rate 
(1/sec) were assessed with two-dimensional speckle tracking echocardiography using previously 
published image acquisition and data analysis protocols from our laboratories.2,9 Longitudinal strain 
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is a measure of the maximal shortening of myocardial longitudinal length during systole compared to 
the resting length in diastole. The speed at which the myocardial wall deforms and then returns to 
baseline is measured as the time derivate of strain in systole and diastole, referred to as systolic and 
early and late diastolic strain rate, respectively. A frame rate to heart rate ratio between 0.7 and 0.9 
frames/sec per beats per minute was utilized to optimize myocardial speckle tracking and 
mechanical event timing.9 Peak strain for each index was measured as end-systolic strain at the 
closure of the aortic valve.16 Two observers, who were blinded to the maternal and infant clinical 
and cardio-respiratory conditions, analyzed deformation using vendor customized commercially 




LV morphology was assessed LV mass index (LVMi) and relative wall thickness (RWT) and according 
to previously published guidelines.11 The estimation of LVMi and RWT were derived from LV 
measurements obtained by two-dimensional guided M-mode echocardiography using the parasternal 
short-axis view at the level of the papillary muscles. End diastole was defined as the time of maximum 
LV dimension. We measured end diastole interventricular septal thickness (IVSd), left ventricular (LV) 
posterior wall thickness (LVPWd), and LV dimension at end diastole (LVEDD) and end systole 
(LVESD) over three consecutive cardiac cycles and averaged the values. 
A. LVM was estimated by the Devereux equation, LVM (grams) = 0.8{1.04 [(LVEDD + LVPWd + 
IVSd) 3 - (LVEDD)3]} + 0.6.17 We indexed LVM to allow comparisons between term and preterm 
infants with different body sizes. In this study, LVM was normalized to height to the allometric 
power of 2.7 to obtain LVMi.18 Although whether to use height, weight, or BSA as the indexing 
term is unclear in children, it has been previously shown that LV mass centile curves indexed to 
weight, length, and BSA are all practical method to assess LV morphology in preterm infants. 
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Accordingly, we included these analyses to assess LV morophology.19 We used the Haycock 
formula for calculation of body surface area: weight0.5378 × height0.3964 × 0.024265.20 Since altered 
LV geometry in preterm infants is also associated with steroid use,15 we also accounted for its 
postnatal use in the model.  
B. Relative wall-thickness (RWT) was calculated using two formulas: (1) RWT equals twice the 
posterior wall thickness (LVPWd) over LVEDD; (2) RWT equals the ratio of the sum of LVPWd 
and IVSd over LVEDD.21 In the result section, we present RWT determined with twice the LVPWd 
over LVEDD rather than RWT equals the ratio of the sum of LVPWd plus IVSd due to the potential 
interference by tricuspid valve tissue and right ventricular trabeculations with septal measurement.15 
 
RV Function 
The major contribution to ejection fraction and stroke volume for the RV during systole is provided by 
the dominant deep longitudinal fiber layer, which makes up 80% of the RV free wall thickness. In this 
study, RV performance was assessed using measures that assess changes in RV longitudinal shortening 
from one of three distinct approaches in neonates:12 (i) change in cavity dimensions (e.g. fractional are 
of change, FAC) (ii) displacement and velocity of single point along the myocardial wall (e.g. tricuspid 
annular plane systolic excursion, TAPSE); and (iii) deformation of a segment of the wall (strain and 
strain rate imaging).22  
A. FAC (%) reflects a change in cavity size and is a surrogate of RV ejection fraction.1 FAC is 
calculated by tracing the endocardial borders, including the trabeculations with the area, at end-
diastole and end-systole and applying these measurements to the following equation: [(end-diastole 
area - end-systolic area)/ end-diastole area] x 100. FAC was measured from the apical 4 –chamber 
view. 
B. TAPSE (mm) measures the longitudinal distance (displacement) that the tricuspid valve annulus 
moves during systole. Contraction of the deep longitudinal fibers of the RV free wall pull the 
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tricuspid valve from the base to the apex during systole. TAPSE measures this dominant component 
of RV systolic performance and provides an estimate of longitudinal myocardial shortening. For this 
study, TAPSE was obtained at the level of the lateral TV annulus using M-Mode. 
C. The same deformation approach utilized from the LV was applied to the RV, but assessment of RV 
longitudinal strain and strain rate images were acquired from an RV focused apical four chamber 
view according to previous published protocols.2,13 
RV Morphology 
RV morphology was assessed with RV areas1,23 and RV linear dimensions.3 
A. RV areas were assessed from the RV focused apical 4-chambier view in systole and diastole. 
B. RV linear dimensions were measured at the basal and mid ventricular levels and in the longitudinal 
direction from the apical 4-chamber view at end-diastole.4,10,11 
 
RV Afterload/Pulmonary Hemodynamics 
We measured several different markers of RV afterload to account for its two main components, 
pulmonary vascular resistance and compliance.24 Specifically, we measured pulmonary artery pressure 
derived by both the tricuspid regurgitation jet velocity, when available, and RV systolic time intervals. 
A. Pulmonary artery systolic pressure was estimated by the tricuspid regurgitation jet velocity, when 
available 
B. Pulmonary artery systolic pressure was estimated by RV systolic time intervals, also known as  
pulmonary artery acceleration time (PAAT) and its ratio to right ventricle ejection time (RVET) to 
PAAT (PAATi).14 PAAT and PAATi have been validated against cardiac catheterization in children 
and neonates,24 and maturational patterns have recently been established in healthy children25 and 
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RV Function to RV Afterload Coupling 
The RV and pulmonary arterial (PA) circulation function as one unit, commonly referred to as the RV-
PA axis.26 Recent evidence suggests an index of ventriculo-arterial coupling can serve as a 
comprehensive measure of RV- PA axis with different neonatal outcomes.27 Accordingly, we assessed 
the relationship of TAPSE (a measure of RV longitudinal shortening) to PAATi (a comprehensive 
measure of RV afterload) as a surrogate of RV-PA coupling.28,29 
 
Common Neonatal Morbidities 
The following additional common neonatal outcomes were evaluated: intraventricular hemorrhage 
(classified according to Papile Classification),30 retinopathy of prematurity (stage 2 or higher), 
necrotizing enterocolitis (Bells Stage II, with radiological evidence of pneumatosis), BPD (we used a 
modified version of 2001 National Institutes of Health workshop definition of bronchopulmonary 
dysplasia),6 and late PH. Preterm infants were classified with late pulmonary hypertension if they had 
two or more of the following conventional echocardiographic measures of pulmonary hemodynamics at 
any of the echocardiograms: 1) an estimated right ventricle systolic pressure > 40 mmHg, using the 
Doppler velocity of tricuspid regurgitation, 2) a ratio of right ventricle systolic pressure to systemic 
blood pressure  > ½; 3) bidirectional or right to left shunt at the atrial level or patent ductus arteriosus; 4) 
septal wall flattening as defined as decreased septal curvature into the RV at end systole, or 5) 
dilated/hypertrophy of the right ventricle and right atrial morphology.4,14  
 
Sample Size Justification: Power Analysis 
To overcome the limitations of enrolling enough patients at specific gestational ages with certain 
weights to detect statistically significant differences, our initial calculations on the basis of preliminary 
analysis and literature searches determined that we needed 150 patients to detect a 20% difference in LV 
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systolic and RV systolic strain to expect moderate associations between MoM and strain (r = 0.3). Our 
design maintains 90% power for this effect size with n = 150 and 95% power with n = 170. The larger 
sample size allows power to detect variability in rates of change in our trajectory models, as well as 90% 
power for group differences of d = 0.43 and r = 0.20. The sample size of 170 assumes a missing rate of 
10% (5% because of late deaths and 5% because of loss to follow-up) that would allow for a power of 
>80% to detect a significant association at an odds ratio of ≥1.30 for each 1-SD increase in RV and LV 
strain associated with gestational age. This calculation assumed no measurement errors and no 
correlation between strain and other covariates and a conservative 50% rate of BPD and 20% PH. In 
addition to account for the potential limitation of enrolling enough patients at specific gestational ages 
with certain weights to detect statistically significant differences, we decided to also generate 
maturational patterns and compare them between preterm-born infants in the high MoM, preterm-born 
infants in the low MoM, and term-born control infants at one year of age.  
 
EXPANDED RESULTS 
Characteristics of Cohorts 
One hundred and eighty infants (80 born preterm and 100 born at term) were included in this study 
(Figure 1). In the original Prematurity and Respiratory Outcomes Program (PROP) at the Washington 
University School of Medicine site, 137 infants were recruited at birth. Of the 137 preterm infants 
recruited at birth, 13 died, two withdrew, and five transferred before completion of the study. At 32 and 
36 weeks PMA, 117 infants were evaluated with an echocardiogram. Of the 117 alive at discharge, 37 
were lost to follow-up and 80 preterm infants returned at 1 year CA. Only infants with echocardiograms 
at 32 weeks PMA, 36 weeks PMA and 1 year CA were included in this study. A cohort of 100 healthy, 
age- and sex-matched infants born at term were recruited for the control group and had echocardiograms 
performed at 1 month and 1 year of age. The median gestational age at birth of the 100 term-born infants 
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was 39.0 weeks (IQR 38.0 – 40.0) and the median birth weight was 3165 g (IQR 2900–3760). Of the 
100 term infants, 54 were white and 46 were black. 
Clinical Data Reporting 
The clinical information that was not described in Table 1 is detailed below in this supplement 
explanation. In this study, none of the preterm infants received inotropes, inhaled nitric oxide or other 
pulmonary vasodilators at any time point in the first year of age. Additionally, none of the preterm born 
infants were on respiratory support at 1 year CA. In our neonatal intensive care unit, all preterm infants 
born less than 29 weeks gestation received caffeine from birth through 34 weeks PMA, and none 
received it beyond 34 weeks PMA. Twenty-six preterm infants (33%) received postnatal steroids at least 
one time during their hospital course, of which 23 (88%) received them to treat lung disease beyond the 
first month of age. There was no significant difference in postnatal steroid administration based on MoM 
exposure (p=.13).  Of the 23 infants that received postnatal steroids to treat lung disease beyond the first 
month of age, all were diagnosed with BPD. Of this subset, there was also no significant difference in 
postnatal steroid administration base on MoM exposure( p=.45). The three (12%) infants who did not 
develop BPD received steroids in the first month of age to facilitate a trial of extubation.  At least one 
dose of diuretics was administered to 15 (18%) of the preterm infants during their neonatal course.  All 
15 were on a diuretic at 32 weeks PMA, but off by 36 weeks PMA and remained off at 1 year CA. There 
was no statistical difference in any of the cardiac indices between those infants that did and did not 
receive diuretics (p=.43), or postnatal steroids (p=.49), although the study was not adequately powered 
to answer these questions.  
 A patent ductus arteriosus (PDA) was present on echocardiogram at 32 weeks PMA in 20% 
(n=16) of infants. A PDA was present on echocardiogram at 36 weeks PMA in 10% (n=8) of group. At 
1 year of age, a PDA was not present in any of the infants. There were no differences in cardiac function 
or morphology based on MoM exposure and presence of a PDA, adjusted for gestational age, sex, PDA 
size, diagnosis of BPD and late PH (p > .05 for all measures at 32 and 36 weeks PMA, and 1 year CA). 
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Similarly, there was no difference in measures of cardiac performance at 32 and 36 weeks PMA or 1 
year CA based on MoM exposure and those that required medical (22/80, 28%) and/or surgical 
intervention (12/80, 15%) to augment closure of the PDA. None of the infants had their PDA closed 
with a transcatheter device as this study was performed prior to the availability of the transcatheter 
device at our center. There was no PDA present at 1 month or 1 year of age in the term population and 
no PDA present at 1 year of age in the preterm or term populations. 
 
LV Morphology, RWT 
At 1 year CA multivariate analysis demonstrated that for each additional week of MoM exposure there 
was decreased RWT (p<.001) (Table 2). Linear regression analysis demonstrated negative correlation 
between RWT at 1 year CA and days of MoM exposure (r= -.62, p< .001). Compared to term infants at 
1 year of age, RWT was larger in the preterm infants with high MoM exposure (p<.001). There was no 
difference in RWT at 32 weeks PMA or 36 weeks PMA base on the exposure of MoM (eTable 3). 
 
Dose Response: High vs. Low MoM Cut-off  
Of 80 preterm-born infants, 42 (53%) were exposed to > 28 days of MoM (high MoM) and 38 (47%) 
were exposed to < 28 days of MoM (low MoM). eFigure 4 and eFigure 5 dichotomize the group by 
high vs. low MoM exposure at 1 year CA and allow for comparison of the primary cardiopulmonary 
outcomes to term infants. 
 
Maturational Patterns of LV performance  
LV function, as characterized by the magnitude of LV longitudinal strain, increased from 32 weeks to 1 
year of age in both the preterm and term infants. (eFigure 6). Similarly, LVMI also increased from 32 
weeks to 1 year of age in both the preterm and term infants. Compared to term-born infants, all measures 
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of LV function were similar (p>.05) and LV morphology different (p<.05) at 32 weeks PMA with both 
exposure groups (eTable 2).  
 
Maturational Patterns of RV Performance  
The magnitudes of RV longitudinal strain, FAC, and TAPSE increased from 32 weeks PMA to 1 year 
CA in both the preterm and term infants (eFigure 6). RV morphology measures of systolic and diastolic 
areas, basal, mid-cavity, and apex-to-base linear dimensions also increased in both the preterm and term 
infants from 32 weeks postmenstrual age to 1 year CA (p<.01 for all measures). Compared to term 
infants, all preterm infants at 32 weeks PMA had decreased magnitudes of RV function and 
morphometric measures (P<.05 for all measures) (eTable 2). 
 
Maturational Patterns of RV Afterload and Coupling 
PAATi decreased from 32 weeks PMA to 1 year of CA in both the preterm and term infants (P<.05) 
(eFigure 7). RV to PA coupling (TAPSE/PAATi) increased from 32 weeks PMA to 1 year CA in in 
both the preterm and term infants (P<.05) (eFigure 7).   
 
Discharge Nutritional Status 
eTable 4 summarizes the comparisons between infants discharged on MoM vs. infants discharged on 
Formula. There were 26 (33%) of infants’ discharge on only MoM with a mean (standard deviation) of 
59 days (10) on MoM. There were 54 (67%) of infants discharged on formula with a mean (standard 
deviation) of 22 days (15) on MoM. The mean and standard deviation in length of stay was similar 
between the two groups [91(23) vs. 94(22), p =.34]. Infants discharged on MoM had enhanced LV 
function, RV function, changes in LV and RV morphology, and measures of RV afterload at 1 year CA 














 We did not explore factors that may influence a mother’s ability to provide breast milk to her preterm 
infant during the neonatal period or at discharge.31 Although preterm infants who received MoM at 
discharge in this study had enhanced cardiopulmonary function compared to infants who received 
formula at discharge, future work is needed to explore factors affecting breastfeeding outcomes in 
preterm infants and why a preterm infant would have higher exposure to MoM, as these factors 




















eTable 1. Comparison of Cardiac Parameters at 1 Year of Age  
 Preterm-born infant   Term-born     
 High MoM (n-=42) Low MoM (n=38) P value a Controls (n=100) P value b P value c 
     Age at echocardiogram (days) 479 (461, 515) d 501 (469, 536) d .17 378 (365, 399) .35 .25 
     Weight at echocardiogram (kg) 9.7 (8.7, 11.1) 9.8 (9.0, 10.7) .43 10.1 (9.1, 11.5) .22 .43 
     Body surface area (m2) e .46 (0.42, 0.47) .45 (0.43, 0.48) .23 .45 (0.43, 0.49) .46 .33 
     Heart rate (beats/minutes) 128 (115, 139) 127 (116, 137) .36 125 (119-133) .66 .26 
Left ventricle function       
      Longitudinal strain (%) -20.2 (3.1) -17.9 (2.4) .02 -22.3 (2.4) .006 .002 
      Longitudinal systolic strain rate (1/sec) -1.6 (.23) -1.3 (.4) .04 -1.8 (.19)  <.001 <.001 
      Longitudinal early diastolic strain rate (1/sec) 2.5 (.34) 2.2 (.41) .01 2.8 (.29) <.004 <.01 
      Longitudinal late diastolic strain rate (1/sec) 2.3 (.31) 2.0 (.26) .03 2.6 (.15) <.002 <.01 
Left ventricle Morphology       
      LV mass index (g/h2.7) 45 (4) 43 (3) <.001 49 (5) <.001 <.001 
      Relative wall thickness f .31 (.07) .33 (.04) <.001 .28 (.04) <.001 <.001 
Right ventricle function       
      Fractional area of change  (%) 38 (4) 33 (3) .01 43 (4) <.001 <.001 
      Tricuspid annular plane systolic excursion (mm) 17 (3) 15 (4) .03 19 (5) .003 .005 
      Longitudinal strain (%) -30.3 (2.4) -27.4 (3.1) .002 -33.6 (2.7) <.001 <.001 
      Longitudinal systolic strain rate (1/sec) -2.2 (.13) -1.9 (.28) .001 -2.8 (.31) <.001 <.001 
      Longitudinal early diastolic strain rate (1/sec) 3.1 (.41) 2.6 (.27) .004 3.5 (.34) <.001 <.001 
      Longitudinal late diastolic strain rate (1/sec) 2.9 (.39) 2.3 (.25) .007 3.6 (.28) <.001 <.001 
Right ventricle Morphology       
      Basal length (cm) 2.4 (.49) 2.6 (.23) .02 2.2 (.20) <.001 <.001 
      Mid-cavity length (cm) 1.8 (.31) 2.0 (.22) .03 1.6 (.24) <.001 <.001 
      Major length (cm) 4.0 (.53) 4.0 (.34) .34 4.1 (.39) .28 .26 
      Systolic area (cm2) 4.3 (.29) 3.6 (.31) .01 4.5 (.21) <.001 <.001 
      Diastolic area (cm2) 6.5 (.23) 6.2 (.17) .02 6.8 (.46) <.001 <.001 
Right ventricle afterload       
      Pulmonary artery acceleration time (PAAT, ms) 79 (15) 63 (12) <.001 97 (13) <.001 <.001 
      PAATi (RVET / PAAT) 2.9 (.31) 3.8 (.42) <.001 2.3 (.36) <.001 <.001 
  
Data presented at median (Interquartile range) or mean (standard deviation) 
Abbreviations: LV, left ventricle; MoM, mother’s own breast milk; PAATi, indexed pulmonary artery 
acceleration time; RV, right ventricle; RVET, right ventricle ejection time 
a Preterm born high MoM vs. Preterm born low MoM. Comparisons adjusted for age, sex, bronchopulmonary 
dysplasia and late pulmonary hypertension. 
b Term born vs. Preterm born high MoM. Comparisons adjusted for age, sex, bronchopulmonary dysplasia, late 
pulmonary hypertension, and necrotizing enterocolitis. 
c Term born vs. Preterm born low MoM. Comparisons adjusted for age, sex, bronchopulmonary dysplasia, late 
pulmonary hypertension, and necrotizing enterocolitis. 
d These numbers reflect actual days of age. Corrected age (days) for all preterm infants was 381 (355,424), for 
preterm infants in the high MoM was 388 (361, 419) and preterm infants in the low MoM was 387 (367, 428). 
e We used the Haycock formula for calculation of body surface area: weight0.5378 × height0.3964 × 0.024265. 
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eTable 2. Comparison of Cardiac Parameters at 1 Month of Age  
 Preterm-born infant   Term-born     
 High MoM (n-=42) Low MoM (n=38) P value a Controls (n=100) P value b P value c 
     Age at echocardiogram (days) 38 (35, 48) d 37 (31, 42) d .14 32 (31, 35) .45 .45 
     Weight at echocardiogram (kg) 1.4 (1.2, 1.6) 1.4 (1.2, 1.6) .44 4.6 (4.3, 4.9) .001 .001 
     Body surface area (m2) e .26 (0.24, 0.29) .26 (0.23, 0.28) .53 .27 (0.25, 0.28) .23 .13 
     Heart rate (beats/minutes) 157 (145, 166) 158 (147, 170) .46 155 (129, 166) .26 .16 
Left ventricle function       
      Longitudinal strain (%) -18.1 (3.2) -18.3 (2.9) .23 -19.1 (3.3) .42 .56 
      Longitudinal systolic strain rate (1/sec) -1.5 (.32) -1.4 (.39) .16 -1.6 (.22) .47 .35 
      Longitudinal early diastolic strain rate (1/sec) 2.3 (.18) 2.4 (.36) .43 2.5 (.32) .49 .34 
      Longitudinal late diastolic strain rate (1/sec) 1.9 (.29) 1.9 (.35) .35 2.0 (.31) .39 .89 
Left ventricle Morphology       
      LV mass index (g/h2.7) 38 (4) 39 (4) .11 44 (5) .001 .002 
      Relative wall thickness f .33 (.05) .34 (.06) .64 .31 (.03)) .004 .004 
Right ventricle function       
      Fractional area of change  (%) 32 (3) 32 (4) .25 36 (3) .005 .006 
      Tricuspid annular plane systolic excursion (mm) 8 (2) 8 (1) .44 10 (2) .03 .02 
      Longitudinal strain (%) -18.2 (2.3) -19.1 (3.1) .22 -26.3 (2.5) <.001 <.001 
      Longitudinal systolic strain rate (1/sec) -1.8 (.31) -1.8 (.29) .35 -2.7 (.41) .003 .003 
      Longitudinal early diastolic strain rate (1/sec) 2.1 (.43) 2.1 (.37) .32 2.4 (.37) .01 .02 
      Longitudinal late diastolic strain rate (1/sec) 1.6 (.22) 1.5 (.28) .26 1.8 (.31) <.001 <.001 
Right ventricle Morphology       
      Basal length (cm) 1.3 (.33) 1.3 (.31) .22 1.7 (.23) .001 .001 
      Mid-cavity length (cm) 1.1 (.23) 1.1 (.28) .28 1.3 (.17) .02 .03 
      Major length (cm) 2.1 (.37) 2.3 (.42) .60 3.5 (.43) .008 .008 
      Systolic area (cm2) 1.7 (.31) 1.7 (.32) .28 2.5 (.56) .007 .006 
      Diastolic area (cm2) 2.6 (.29) 2.6 (.34) .40 3.8 (.41) .006 .005 
Right ventricle afterload       
      Pulmonary artery acceleration time (PAAT, ms) 49 (12) 43 (15) .35 75 (13) <.001 <.001 
      PAATi (RVET / PAAT) 3.9 (.33) 4.4 (.54) .22 2.9 (.31) <.001 <.001 
 
Data presented at median (Interquartile range) or mean (standard deviation) 
Abbreviations: LV, left ventricle; MoM, mother’s own breast milk; PAATi, indexed pulmonary artery 
acceleration time; RV, right ventricle; RVET, right ventricle ejection time 
a Preterm born high MoM vs. Preterm born low MoM. Comparisons adjusted for age, sex, bronchopulmonary 
dysplasia and late pulmonary hypertension. 
b Term born vs. Preterm born high MoM. Comparisons adjusted for age, sex, bronchopulmonary dysplasia, late 
pulmonary hypertension, and necrotizing enterocolitis. 
c Term born vs. Preterm born low MoM. Comparisons adjusted for age, sex, bronchopulmonary dysplasia, late 
pulmonary hypertension, and necrotizing enterocolitis. 
d The preterm cohort included infants born between 23 and 0/7 weeks and 28 and 6/7 weeks gestation at birth 
and we choose to study all infants at a common postmenstrual age (PMA) to optimize the determination of the 
impact of gestational and chronological age on cardiac performance at a specific developmental stage and allow 
for comparison of measures between term and preterm infants by post-gestational days from birth. The first 
echocardiogram in the preterm-born infants was acquired at 32 weeks PMA, a median of 38 days (interquartile 
range of 33 to 45 days). 
e We used the Haycock formula for calculation of body surface area: weight0.5378 × height0.3964 × 0.024265. 
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eTable 3. Multivariate Analysis of Cardiac Parameters at 1 Month of Age 
 
Cardiac variable B a 95% CI P value 
  Left ventricle function    
      Longitudinal strain (%) .076 .038, .102 .33 
      Longitudinal systolic strain rate (1/sec) .082 .048, .121 .23 
      Longitudinal early diastolic strain rate (1/sec) .061 .028, .091 .36 
      Longitudinal late diastolic strain rate (1/sec) .066 .042, .087 .51 
  Left ventricle Morphology    
      LV mass index (g/h2.7) .121 .085, .145 .22 
      Relative wall thickness c -.124 -.211, -.104 .42 
  Right ventricle function    
      Fractional area of change  (%) .136 .122, .176 .27 
      Tricuspid annular plane systolic excursion (mm) .132 .121, .146 .41 
      Longitudinal strain (%) .111 .096, .132 .23 
      Longitudinal systolic strain rate (1/sec) .093 .062, .115 .26 
      Longitudinal early diastolic strain rate (1/sec) .105 .088, .143 .45 
      Longitudinal late diastolic strain rate (1/sec) .103 .085, .141 .16 
  Right ventricle Morphology    
      Basal length (cm) -.199 -.331, -.103 .31 
      Mid-cavity length (cm) -.123 -.212, -.071 .46 
      Major length (cm) .079 -0.203, 0.199 .59 
      Systolic area (cm2) .031 .009, .062 .48 
      Diastolic area (cm2) .025 .011, .052 .47 
  Right ventricle afterload    
      Pulmonary artery acceleration time (PAAT, ms) .031 .009, .051 .38 
      PAATi (RVET / PAAT) -.023 -.034, -.019 .12 
a Multivariate analyses reported are adjusted absolute differences in means that correspond to a one 
week increase in mother’s own breast milk (MoM) exposure. Comparisons adjusted for age, sex, 
bronchopulmonary dysplasia, late pulmonary hypertension, and necrotizing enterocolitis. 
LV, left ventricle; PAATi, indexed pulmonary artery acceleration time; RV, right ventricle; RVET, 
right ventricle ejection time.  
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eTable 4. Comparison of Cardiac Parameters at 1 Year of Age based on Discharged Nutrition 
 
 MoM (n=26)    Formula (n=54) P value 
    
Left ventricle function    
      Longitudinal strain (%) -21.4 (2.5) -18 (1.9) .01 
      Longitudinal systolic strain rate (1/sec) -1.7  (.42) -1.4 (.33) .02 
      Longitudinal early diastolic strain rate (1/sec) 2.6 (.38) 2.2 (.31) .01 
      Longitudinal late diastolic strain rate (1/sec) 2.3 (.29) 1.9 (.18) .02 
Left ventricle Morphology    
      LV mass index (g/h2.7) 45 (4) 42 (3) .006 
      Relative wall thickness a 0.31 (.03) 0.33 (.05) .009 
Right ventricle function    
      Fractional area of change  (%) 39 (5) 33 (4) .003 
      Tricuspid annular plane systolic excursion (mm) 17 (3) 15 (2) .01 
      Longitudinal strain (%) -32.4 (3.2) -27.3 (3.3) .002 
      Longitudinal systolic strain rate (1/sec) -2.4 (.21) -2.0 (.35) .008 
      Longitudinal early diastolic strain rate (1/sec) 3.1 (.32) 2.8 (.26) .004 
      Longitudinal late diastolic strain rate (1/sec) 2.9 (.44) 2.4 (.32) .003 
Right ventricle Morphology    
      Basal length (cm) 2.4 (.38) 2.5 (.18) .02 
      Mid-cavity length (cm) 1.7 (.37) 1.9 (.23) .01 
      Major length (cm) 4.1 (.34) 4.0 (.23) .38 
      Systolic area (cm2) 4.4 (.41) 3.7 (.27) .01 
      Diastolic area (cm2) 6.7 (.31) 6.3 (.26) .02 
Right ventricle afterload    
      Pulmonary artery acceleration time (PAAT, ms) 80 (14) 65 (11) .001 
      PAATi (RVET / PAAT) 2.9 (.35) 3.5 (.29) .002 
 
LV, left ventricle; MoM, mother’s own breast milk; PAATi, indexed pulmonary artery acceleration 
time; RV, right ventricle; RVET, right ventricle ejection time.  
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eTable 5. Donor Human Milk Multivariate Analysis of Cardiac Parameters at 1 Year Corrected Age 
 
Cardiac variable B a 95% CI P value 
  Left ventricle function    
      Longitudinal strain (%) .036 .016, .093 .26 
      Longitudinal systolic strain rate (1/sec) .041 .027, .103 .44 
      Longitudinal early diastolic strain rate (1/sec) .052 .019, .082 .51 
      Longitudinal late diastolic strain rate (1/sec) .039 .021, .063 .42 
  Left ventricle Morphology    
      LV mass index (g/h2.7) .061 .043, .093 .17 
      Relative wall thickness b -.091 -.132, -.062 .32 
  Right ventricle function    
      Fractional area of change  (%) .084 .061, .123 <.001 
      Tricuspid annular plane systolic excursion (mm) .091 .073, .121 <.001 
      Longitudinal strain (%) .036 .012, .071 <.001 
      Longitudinal systolic strain rate (1/sec) .061 .033, .097 <.001 
      Longitudinal early diastolic strain rate (1/sec) .075 .043, .122 <.001 
      Longitudinal late diastolic strain rate (1/sec) .056 .028, .089 <.001 
  Right ventricle Morphology    
      Basal length (cm) -.059 -.091, -.021 <.001 
      Mid-cavity length (cm) -.023 -.089, -.005 <.001 
      Major length (cm) .059 -0.03, 0.93 .32 
      Systolic area (cm2) .029 .011, .052 <.001 
      Diastolic area (cm2) .031 .008, .049 <.001 
  Right ventricle afterload    
      Pulmonary artery acceleration time (PAAT, ms) .042 .019, .072 .34 
      PAATi (RVET / PAAT) -.034 -.052, -.009 .39 
a Multivariate analyses reported are adjusted absolute differences in mean that correspond to a one 
week increase in donor human milk exposure. Comparisons adjusted for age, sex, bronchopulmonary 
dysplasia, late pulmonary hypertension, and necrotizing enterocolitis. 
LV, left ventricle; PAATi, indexed pulmonary artery acceleration time; RV, right ventricle; RVET, 
right ventricle ejection time.  
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eFigure 1. Histogram of distribution of days of mother’s own milk (MoM). The low MoM exposure (n=38) 
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eFigure 2.  Linear Regression Analysis at 1 Year of Age for A) PVR and B) Coupling.  PVR, pulmonary 
vascular resistance. PAATi, indexed pulmonary artery acceleration time defined as the ratio of right ventricle 
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eFigure 3. Receiver operator curve analysis to determine specific cutoff values of days of mother’s own milk 
in predicting elevated pulmonary vascular resistance. For detection of elevated pulmonary vascular 
resistance (indexed pulmonary artery acceleation time, PAATi > 3) at 1 year CA, a cut-off < 30 days of 
mother’s own milk exposure resulted in sensitivity of 85% and specificity of 85% with an AUC of .903 (95% 
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eFigure 4. Preterm-born infants in the high mother’s own milk (MoM) exposure group (orange) had 
increased right and left ventricular strain (A and B), and right ventricular areas (C), and left ventricular mass 
index, LMVI, g/h2.7, (D) compared with preterm-born infants in the low MoM exposure group (blue) at 1 
year corrected age. Term-born control infants are shown in green at 1 year of age. High MoM is defined as > 
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eFigure 5. At 1 year of age, preterm-born infants in the high mother’s own milk (MoM) exposure group 
(orange) had lower pulmonary vascular resistance, PVR (A) - as measured by indexed pulmonary artery 
acceleration time (PAATi), and higher RV function to afterload coupling (B) - as measured by the ratio of 
tricuspid annular plane systolic excursion to PAATi compared with preterm-born infants in the low MoM 
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eFigure 6. Comparison of maturational patterns of right and left ventricular strain (A and B), right 
ventricular diastolic area (C), and left ventricular mass index, LMVI, g/h2.7, (D) between preterm-born 
infants in the high mother’s own milk (MoM) exposure group (orange) and the preterm-born infants in the 
low MoM exposure group (blue) over the first year of age. Term-born control infants are shown in green at 1 
year of age. a P < .01 vs. term-born controls; b P < .01 between the high (n=42) and low (n=38) MoM 
exposure groups at each time point (with Bonferroni adjustment). c P < 0.01 change over time within the 
same group (ANOVA). d P < .01  compared with baseline of 32 weeks PMA e The first echocardiogram in 
the preterm-born infants was acquired at 32 weeks PMA at a median of 38 days (interquartile range of 33 to 
45 days). Term infants had their first echocardiogram at a median of 32 days (interquartile range of 31 to 35 
days). f At 1 year corrected age, the corrected age in days for all preterm infants was a median of 381 
(355,324). The term infants received the 1-year of age echocardiogram at a median of 378 days (interquartile 
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eFigure 7.  Comparison of maturational patterns of pulmonary vascular resistance, PVR (A) - as measured 
by indexed pulmonary artery acceleration time (PAATi), and couplings (B) - as measured by the ratio of 
tricuspid annular plane systolic excursion to PAATi between preterm-born infants in the high MoM exposure 
group (orange) and the low MoM exposure group (blue) over the first year of age. Term-born control infants 
are shown in green. a P < .01 vs. term-born controls; b P < 0.01 between the high (n=42) and low (n=38) 
MoM exposure groups at each time point (with Bonferroni adjustment). c P < .01 change over within the 
same group (ANOVA). d P < .01  compared with baseline of 32 weeks PMA. e The first echocardiogram in 
the preterm-born infants was acquired at 32 weeks PMA at a median of 38 days (interquartile range of 33 to 
45 days). Term infants had their first echocardiogram at a median of 32 days (interquartile range of 31 to 35 
days). f At 1 year corrected age, the corrected age in days for all preterm infants was a median of 381 
(355,324). The term infants received the 1-year of age echocardiogram at a median of 378 days (interquartile 
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